Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications response cost meningococcal disease outbreaks university campus settings case study
… Modelling Considerations for Evaluating the Cost-Effectiveness of Biologics Chris Knight, MSc Executive … health states defined by levels of disease and treatment response. However, vague definitions of disease control and a … identifying appropriate treatment stopping rules, finding publications reporting stratified cost and utility estimates, …
… VAC4EU , the Vaccine Monitoring Collaboration for Europe study network, we are helping to increase the availability of … Partners CANADA Saskatchewan Health DENMARK Aarhus University Southern Denmark University ESTONIA University of … Research (CEIFE) The Spanish Working Group on Chron’s Disease and Ulcerative Colitis (GETECCU), holds ENEIDA …
… to Increase Vaccination in Older Adults Worth the Cost? Share on: October 5, 2021 Gaining optimal vaccination … influenza, whooping cough, shingles, and pneumococcal disease. But the number vaccinated is considered suboptimal. … with GSK and RTI Health Solutions conducted an exploratory study to understand the costs and benefits of such a program …
… studies can help you: Understand the natural history of a disease and its treatment Quantify and characterize product … adjudication committees Steering committees Obtaining study approval from Institutional Review Boards and Ethics Committees Managing study operations: Site recruitment Monitoring Incentive …
… Infectious Disease A Wealth of Experience We have collaborated with our … Influenza Invasive fungal infections Malaria Meningococcal disease MRSA Respiratory tract infections … have included: Conjoint analyses Decision-analytic models (cost effectiveness, budget impact) Communicable disease …
… A Cost-Effectiveness Analysis Using Real-World Data William … Natalizumab to Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple …
… local markets. Key sections in a GVD include: Value story Disease burden Unmet needs Value of the product (clinical, … Landscape How rigorously do payers manage the disease? How have payers handled reimbursement of alternative …
… your product’s value proposition. Typical studies include: Study Type Description Burden of Illness Disease incidence and prevalence; real-world outcomes; costs … disease including direct, indirect, and intangible costs; cost of treatment and health-related quality of life; …
… FDA Rare Disease Day 2024 Virtual Public Meeting Share on: Friday, … the US FDA’s Virtual Public Meeting in recognition of Rare Disease Day 2024. In the afternoon session, Romano will be … patient committee participants on the FDA-sponsored study to adapt an in-clinic outcome assessment tool for ALS …
RTI-HS Researchers Outline Best Practices for Collecting Patient Experience Data During the COVID-19 Outbreak Share on: April 9, 2020 Updated November 10, 2020 Experts on our Patient-Centered Outcomes Assessment (PCOA) team collaborated to create this …